Skip to main content

Guidance Documents

1276 Results
Guidance Documents

Prescriptions by e-mail

This guidance document answers the question: “If electronic prescriptions for controlled substances be sent by e-mail.”

ID: DEA-DC-049
Component Diversion Control Program (DEA)
Date Issued: November 20, 2020
Guidance Documents

Best Practices Guide

ATF Industry Operations Investigators (IOIs) assist Federal firearms licensees (FFLs) in understanding and complying with the laws and regulations for operating a firearms business. Whether it is with proper recordkeeping or lawfully transferring firearms, IOIs ensure that FFLs comply with Federal firearms laws and regulations.

ID: DOJ-2040776
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: November 5, 2020
Guidance Documents

QA Double Blind Study

Question and Answer addressing if a Researcher registrant should complete a DEA Form 222 when participating in double-blind studies in which the exact quantity of schedule I or II controlled substances received is unknown.

ID: DEA-DC-048
Component Diversion Control Program (DEA)
Date Issued: October 13, 2020
Guidance Documents

Pharmacist Manual

Pharmacist Manual

ID: DEA-DC-046
Component Diversion Control Program (DEA)
Date Issued: October 8, 2020
Guidance Documents

QA Black Bag Exception

Q&A answering whether a physician transport controlled substances and administer controlled substances at the patient’s home residence (the so-called “black bag exception”).

ID: DEA-DC_047
Component Diversion Control Program (DEA)
Date Issued: October 8, 2020
Guidance Documents

Underground Storage (Presentation)

This presentation provides a history of the implementation of the Safe Explosives Act, the intention of the legislation and the authority of ATF to regulate the storage of explosives, above ground or underground.

ID: DOJ-1382741
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: September 18, 2020
Guidance Documents

Fireworks (Presentation)

This presentation on fireworks provides an overview of the classification of explosive materials and exemptions under Part 555, storage, identifying appropriate Tables of Distances and determining if a variance to deviate from the regulations might be needed.

ID: DOJ-1382791
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: September 18, 2020
Guidance Documents

Employee Possessor (Presentation)

This presentation defines an Employee Possessor and provides the procedures for reporting Employee Possessors to ATF, the clearance process, and at what point an employee may possess explosives.

ID: DOJ-1382806
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: September 18, 2020
Guidance Documents

QA Pharmacy Delivery of Buprenorphine Prescription under SUPPORT Act

Q&A asking if a pharmacy may deliver a prescribed buprenorphine product to a practitioner for direct administration to the patient. This Q&A further explains that a pharmacy may deliver buprenorphine to the registered location of either the prescribing or the administering practitioner, and must be administered by injection or implantation only to the patient named on the prescription within 14 days after the date of receipt of the CS by the practitioner.

ID: DEA-DC-045
Component Diversion Control Program (DEA)
Date Issued: September 18, 2020
Guidance Documents

Type 3 Magazines (Presentation)

This presentation provides an overview of Type 3 magazine construction, reporting requirements and use intended for temporary attended storage on a worksite.

ID: DOJ-1382756
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: September 10, 2020